- Sector
- Financial Services
- Industry
- Asset Management
- Address
- Valley Forge PA 19482 Valley Forge PA United States of America 19482
- IPO Date
- Nov 24, 2023
- Business
- Vanguard International Dividend Growth Fund (Investor Shares) (VIDGX) is an open-end mutual fund managed by The Vanguard Group, Inc., that seeks total return through a combination of current income and dividend growth by investing primarily in common stocks of non-U.S. companies with a record of dividend growth. The fund focuses on large- and mid-cap companies in developed and emerging markets outside the United States, employing a quantitative investment approach to select securities based on dividend growth potential, financial strength, and valuation metrics; it maintains a portfolio diversified across sectors such as financials, industrials, consumer staples, and health care. Vanguard Group, founded in 1975 and headquartered in Malvern, Pennsylvania, serves as the investment manager, providing administrative, transfer agency, and distribution services to the fund, which targets long-term investors seeking international equity exposure with an emphasis on dividend-paying firms.
The fund's portfolio includes holdings in established multinational companies like Nestle SA, Novartis AG, Roche Holding AG, Unilever PLC, and Novo Nordisk A/S, selected for their consistent dividend increases over at least 10 years and favorable growth prospects; it typically invests at least 80% of assets in these dividend growth stocks, with the remainder in similar equities or fixed-income instruments. Geographically, operations span Europe, Asia-Pacific, and emerging markets including Latin America and the Middle East, excluding U.S.-domiciled firms to provide pure international diversification. As of late 2025, the fund reports a net expense ratio of 0.45%, minimum initial investment of $3,000 for investor shares, and serves individual investors, financial advisors, and institutional clients through Vanguard's platform.
Recent developments include a portfolio rebalancing in 2024 to increase exposure to European healthcare and Asian technology dividend growers amid global market volatility, alongside Vanguard's broader strategic shift toward enhanced ESG integration in quantitative models without altering the core dividend growth mandate. In 2025, the fund benefited from Vanguard Group's launch of complementary low-cost international dividend-focused ETFs, expanding product offerings for investors; no major acquisitions, funding rounds, or name changes occurred, as Vanguard maintains its mutual structure under parent oversight. These adjustments reflect ongoing adaptations to rising interest rates and geopolitical tensions affecting international yields.